Provision Healthcare joins the global association of RayCare clinical partners
Provision, located in Knoxville, Tennessee, is the latest to partner with RaySearch Laboratories on the development of its next-generation oncology information system, RayCare®. The global association of RayCare clinical partners now consists of, in order of entry: UMC Groningen, Iridium Kankernetwerk, UCSF, MD Anderson Cancer Center, University of Wisconsin–Madison and Provision CARES Proton Therapy Centers.
RaySearch started out with a vision for radiation therapy treatment planning. This became the foundation for the RayStation treatment planning system, which already embodies much of that vision and continues to evolve. But while RayStation provides a comprehensive set of tools and calculation services for treatment planning, the full extent of its possibilities can only be achieved in combination with an equally capable oncology information system. This fact was the starting point for RayCare.
RaySearch’s clinical partners play a central role in the development of RayCare. They provide input on what an oncology information system should provide for various types of treatments, for different roles within healthcare teams and, ultimately, for patients. This input feeds into RaySearch’s agile development, and new software versions are regularly provided to the partners so they can provide feedback on the implementation.
The RayCare clinical partners encompass different types of cancer care providers, with varied areas of excellence. Provision brings a strong focus on developing, managing and operating comprehensive cancer centers featuring proton therapy, bringing know-how needed to provide the highest possible quality of cancer care.
Niek Schreuder, Vice President and Chief Medical Physicist for Provision Healthcare, says: “For Provision, it is of great strategic importance for our Cancer CARE Network to have an integrated and efficient solution for patient treatment and care. RaySearch has the competence and innovative focus that Provision needs, and we share a vision of the future of cancer care.”
Johan Löf, CEO of RaySearch says: “In 2014, the Provision CARES Proton Therapy Center, Knoxville, became the first center in the world to use RayStation for clinical proton treatments. The Provision team continues to push the frontiers of radiation therapy, and we are proud to have them on board for the development of RayCare.”
About RayCare
RayCare is a next generation OIS developed from the ground up by RaySearch to support the complex logistical challenges in modern, large-scale radiation therapy centers. RayCare integrates the high performance radiation therapy algorithms available in RayStation and adds advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare, which comprises a new product area for RaySearch, and which will be launched in December 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on NASDAQ Stockholm since November 2003.
More information about RaySearch is available at www.raysearchlabs.com
About Provision Healthcare
Provision Healthcare, LLC (Provision) was formed in 2005 with the purpose of developing innovative healthcare solutions focused on improving patient care and clinical outcomes and developing support for research, educational and charitable causes. Provision has developed a unique, comprehensive expertise in proton therapy that distinguishes it from other proton and cancer center developers and operators that have a much narrower focus. The combination of unique expertise and an innovative, entrepreneurial approach continues to propel Provision towards a position of industry leadership with respect to both cancer care and proton therapy.
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com
or
Nancy Howard
Provision Healthcare, Knoxville, TN
+1 (865) 603-0865
nancy.howard@provisionproton.com
Tags:
